{"id":5535,"date":"2013-09-15T11:12:26","date_gmt":"2013-09-15T11:12:26","guid":{"rendered":"http:\/\/test-medrazgl.aed-baza.si\/?p=5535"},"modified":"2013-09-15T11:12:26","modified_gmt":"2013-09-15T11:12:26","slug":"proportion-of-activated-platelets-in-untreated-and-splenectomized-patients-with-idiopathic-thrombocytopenic-purpura","status":"publish","type":"post","link":"https:\/\/medrazgl.si\/en\/proportion-of-activated-platelets-in-untreated-and-splenectomized-patients-with-idiopathic-thrombocytopenic-purpura\/","title":{"rendered":"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura"},"content":{"rendered":"<p>BACKGROUND. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder of blood haemostasis with thrombocytopenia. The incidence of bleeding in ITP patients is lower than may be predicted on the basis of the platelet count. The proportion of activated platelets in patients with untreated ITP and in splenectomized ITP patients in remission was evaluated. METHODS. Two groups of ITP patients were chosen. The first included untreated ITP patients and the second consisted of splenectomized ITP patients in remission. The proportion of acti\u00advated platelets was determined for each group and compared with the control group. RESULTS. The untreated group had a significantly higher (p = 0.0042) proportion of activat\u00aded platelets than the control group. The group of splenectomized patients in remission showed no significant\u00a0difference in the proportion of activated platelets compared to the control group.\u00a0CONCLUSIONS. ITP patients in remission and without therapy have a higher proportion of acti\u00advated platelets than the healthy population, which could explain their low bleeding tendency. On the other hand, splenectomized ITP patients in remission have the same proportion of activated platelets in their blood as the healthy population and this emphasizes the prima\u00adry importance of the spleen in ITP patients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BACKGROUND. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder of blood haemostasis with thrombocytopenia. The incidence of bleeding in ITP patients is lower than may be predicted on the basis of the platelet count. The proportion of activated platelets in patients with untreated ITP and in splenectomized ITP patients in remission was evaluated. METHODS. Two [&hellip;]<\/p>\n","protected":false},"author":28,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[376,426],"tags":[],"class_list":["post-5535","post","type-post","status-publish","format-standard","hentry","category-3-2007-archive","category-internal-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura - Dru\u0161tvo Medicinski razgledi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura - Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"og:description\" content=\"BACKGROUND. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder of blood haemostasis with thrombocytopenia. The incidence of bleeding in ITP patients is lower than may be predicted on the basis of the platelet count. The proportion of activated platelets in patients with untreated ITP and in splenectomized ITP patients in remission was evaluated. METHODS. Two [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/\" \/>\n<meta property=\"og:site_name\" content=\"Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-15T11:12:26+00:00\" \/>\n<meta name=\"author\" content=\"Sara Mugerli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sara Mugerli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/\"},\"author\":{\"name\":\"Sara Mugerli\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/16ac1255597e2446044919a9c6902c99\"},\"headline\":\"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura\",\"datePublished\":\"2013-09-15T11:12:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/\"},\"wordCount\":210,\"commentCount\":0,\"articleSection\":[\"3\",\"Internal Medicine\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/\",\"name\":\"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura - Dru\u0161tvo Medicinski razgledi\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\"},\"datePublished\":\"2013-09-15T11:12:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/16ac1255597e2446044919a9c6902c99\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/\",\"name\":\"Dru\u0161tvo Medicinski razgledi\",\"description\":\"Dru\u0161tvo Medicinski razgledi\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medrazgl.si\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/16ac1255597e2446044919a9c6902c99\",\"name\":\"Sara Mugerli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2986e968b4413be533684bfc019b504b946f9a82220511cb4bcf7a3428a735dd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2986e968b4413be533684bfc019b504b946f9a82220511cb4bcf7a3428a735dd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2986e968b4413be533684bfc019b504b946f9a82220511cb4bcf7a3428a735dd?s=96&d=mm&r=g\",\"caption\":\"Sara Mugerli\"},\"url\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/author\\\/sara-mugerli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura - Dru\u0161tvo Medicinski razgledi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/","og_locale":"en_US","og_type":"article","og_title":"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura - Dru\u0161tvo Medicinski razgledi","og_description":"BACKGROUND. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder of blood haemostasis with thrombocytopenia. The incidence of bleeding in ITP patients is lower than may be predicted on the basis of the platelet count. The proportion of activated platelets in patients with untreated ITP and in splenectomized ITP patients in remission was evaluated. METHODS. Two [&hellip;]","og_url":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/","og_site_name":"Dru\u0161tvo Medicinski razgledi","article_published_time":"2013-09-15T11:12:26+00:00","author":"Sara Mugerli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sara Mugerli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/#article","isPartOf":{"@id":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/"},"author":{"name":"Sara Mugerli","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/16ac1255597e2446044919a9c6902c99"},"headline":"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura","datePublished":"2013-09-15T11:12:26+00:00","mainEntityOfPage":{"@id":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/"},"wordCount":210,"commentCount":0,"articleSection":["3","Internal Medicine"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/","url":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/","name":"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura - Dru\u0161tvo Medicinski razgledi","isPartOf":{"@id":"https:\/\/medrazgl.si\/#website"},"datePublished":"2013-09-15T11:12:26+00:00","author":{"@id":"https:\/\/medrazgl.si\/#\/schema\/person\/16ac1255597e2446044919a9c6902c99"},"breadcrumb":{"@id":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medrazgl.si\/delez-aktiviranih-trombocitov-pri-bolnikih-z-idiopaticno-trombocitopenicno-purpuro-brez-zdravljenja-in-bolnikih-zdravljenih-s-splenektomijo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medrazgl.si\/en\/"},{"@type":"ListItem","position":2,"name":"Proportion of Activated Platelets in Untreated and Splenectomized Patients with Idiopathic Thrombocytopenic Purpura"}]},{"@type":"WebSite","@id":"https:\/\/medrazgl.si\/#website","url":"https:\/\/medrazgl.si\/","name":"Dru\u0161tvo Medicinski razgledi","description":"Dru\u0161tvo Medicinski razgledi","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medrazgl.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/16ac1255597e2446044919a9c6902c99","name":"Sara Mugerli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2986e968b4413be533684bfc019b504b946f9a82220511cb4bcf7a3428a735dd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2986e968b4413be533684bfc019b504b946f9a82220511cb4bcf7a3428a735dd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2986e968b4413be533684bfc019b504b946f9a82220511cb4bcf7a3428a735dd?s=96&d=mm&r=g","caption":"Sara Mugerli"},"url":"https:\/\/medrazgl.si\/en\/author\/sara-mugerli\/"}]}},"_links":{"self":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/5535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/comments?post=5535"}],"version-history":[{"count":0,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/5535\/revisions"}],"wp:attachment":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/media?parent=5535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/categories?post=5535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/tags?post=5535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}